Cargando…

Evaluation of circulating levels of CCN2/connective tissue growth factor in patients with ST-elevation myocardial infarction

CCN2/Connective tissue growth factor seems to be involved in development of cardiac hypertrophy and fibrosis, but a possible cardioprotective role in left ventricular (LV) remodelling following myocardial infarction has also been suggested. The main objectives of the study were therefore to investig...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ritschel, Vibeke, Shetelig, Christian, Seljeflot, Ingebjørg, Limalanathan, Shanmuganathan, Hoffmann, Pavel, Halvorsen, Sigrun, Arnesen, Harald, Eritsland, Jan, Andersen, Geir Øystein
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5607271/ https://www.ncbi.nlm.nih.gov/pubmed/28931920 http://dx.doi.org/10.1038/s41598-017-12372-w

Ejemplares similares

Markers of Thrombin Generation Are Associated With Long-Term Clinical Outcome in Patients With ST-Segment Elevation Myocardial Infarction
por: Hansen, Charlotte Holst, et al.
Publicado: (2018)

Osteoprotegerin levels in ST-elevation myocardial infarction: Temporal profile and association with myocardial injury and left ventricular function
por: Shetelig, Christian, et al.
Publicado: (2017)

Circulating Levels of IL‐6 Receptor and gp130 and Long‐Term Clinical Outcomes in ST‐Elevation Myocardial Infarction
por: Ritschel, Vibeke N., et al.
Publicado: (2016)

Neutrophil Extracellular Trap Components Associate with Infarct Size, Ventricular Function, and Clinical Outcome in STEMI
por: Helseth, Ragnhild, et al.
Publicado: (2019)

Double-Stranded DNA and NETs Components in Relation to Clinical Outcome After ST-Elevation Myocardial Infarction
por: Langseth, Miriam Sjåstad, et al.
Publicado: (2020)

Glucose associated NETosis in patients with ST-elevation myocardial infarction: an observational study
por: Helseth, Ragnhild, et al.
Publicado: (2019)

Association of Interleukin 8 and Myocardial Recovery in Patients with ST-Elevation Myocardial Infarction Complicated by Acute Heart Failure
por: Husebye, Trygve, et al.
Publicado: (2014)

Effect of Ischemic Postconditioning on Infarct Size in Patients With ST‐Elevation Myocardial Infarction Treated by Primary PCI Results of the POSTEMI (POstconditioning in ST‐Elevation Myocardial Infarction) Randomized Trial
por: Limalanathan, Shanmuganathan, et al.
Publicado: (2014)

High levels of interleukin-6 are associated with final infarct size and adverse clinical events in patients with STEMI
por: Tøllefsen, Ingvild Maria, et al.
Publicado: (2021)

IgM antibodies against phosphorylcholine measured early after acute ST-elevation myocardial infarction in relation to atherosclerotic disease burden and long-term clinical outcome
por: Knudsen, Eva Cecilie, et al.
Publicado: (2019)

MR findings of microvascular perfusion in infarcted and remote myocardium early after successful primary PCI
por: Bethke, Anne, et al.
Publicado: (2018)

Abnormal glucose regulation in patients with acute ST- elevation myocardial infarction-a cohort study on 224 patients
por: Knudsen, Eva C, et al.
Publicado: (2009)

Markers of thrombin generation are associated with myocardial necrosis and left ventricular impairment in patients with ST-elevation myocardial infarction
por: Hansen, C. H., et al.
Publicado: (2015)

Impact of newly diagnosed abnormal glucose regulation on long-term prognosis in low risk patients with ST-elevation myocardial infarction: A follow-up study
por: Knudsen, Eva C, et al.
Publicado: (2011)

Myocardial Salvage is Reduced in Primary PCI-Treated STEMI Patients with Microvascular Obstruction, Demonstrated by Early and Late CMR
por: Limalanathan, Shanmuganathan, et al.
Publicado: (2013)

The Time Profile of Pentraxin 3 in Patients with Acute ST-Elevation Myocardial Infarction and Stable Angina Pectoris Undergoing Percutaneous Coronary Intervention
por: Helseth, Ragnhild, et al.
Publicado: (2014)

Postconditioning in ST-elevation myocardial infarction: a systematic review, critical appraisal, and meta-analysis of randomized clinical trials
por: Abdelnoor, M, et al.
Publicado: (2014)

The Influence of Autologous Bone Marrow Stem Cell Transplantation on Matrix Metalloproteinases in Patients Treated for Acute ST-Elevation Myocardial Infarction
por: Furenes, Eline Bredal, et al.
Publicado: (2014)

Increased levels of CRP and MCP-1 are associated with previously unknown abnormal glucose regulation in patients with acute STEMI: a cohort study
por: Knudsen, Eva C, et al.
Publicado: (2010)

Neutrophil extracellular trap components and myocardial recovery in post-ischemic acute heart failure
por: Langseth, Miriam Sjåstad, et al.
Publicado: (2020)

Prevalence of risk factors at presentation and early mortality in patients aged 80 years or older with ST-segment elevation myocardial infarction
por: Claussen, Peter Andreas, et al.
Publicado: (2014)

Prothrombotic markers in patients with acute myocardial infarction and left ventricular thrombus formation treated with pci and dual antiplatelet therapy
por: Solheim, Svein, et al.
Publicado: (2013)

Cytokine pattern in patients with ST-elevation myocardial infarction treated with the interleukin-6 receptor antagonist tocilizumab
por: Woxholt, Sindre, et al.
Publicado: (2023)

Platelet-, monocyte-derived and tissue factor-carrying circulating microparticles are related to acute myocardial infarction severity
por: Chiva-Blanch, Gemma, et al.
Publicado: (2017)

The Time Course of Markers of Neutrophil Extracellular Traps in Patients Undergoing Revascularisation for Acute Myocardial Infarction or Stable Angina Pectoris
por: Helseth, Ragnhild, et al.
Publicado: (2016)

The Effect of Intracoronary Stem Cell Injection on Markers of Leukocyte Activation in Acute Myocardial Infarction
por: Helseth, Ragnhild, et al.
Publicado: (2015)

Markers of hypercoagulability in CAD patients. Effects of single aspirin and clopidogrel treatment
por: Bratseth, Vibeke, et al.
Publicado: (2012)

The role of interleukin-18 in the metabolic syndrome
por: Trøseid, Marius, et al.
Publicado: (2010)

Asymmetric Dimethylarginine Levels are Highly Associated With Atrial Fibrillation in an Elderly Population
por: Seljeflot, Ingebjorg, et al.
Publicado: (2012)

Very Long Chain Marine n-3 Polyunsaturated Fatty Acids in Atherothrombotic Heart Disease. A Brief Review, with a Focus on Metabolic Effects
por: Arnesen, Harald, et al.
Publicado: (2020)

A brief review on resistance to P2Y(12) receptor antagonism in coronary artery disease
por: Warlo, Ellen M. K., et al.
Publicado: (2019)

von Willebrand factor, ADAMTS-13, and thrombospondin 1 in relation to clinical outcomes in elderly patients with a recent myocardial infarction
por: Warlo, Ellen M.K., et al.
Publicado: (2023)

Tocilizumab increases citrullinated histone 3 in non-ST segment elevation myocardial infarction
por: Helseth, Ragnhild, et al.
Publicado: (2021)

Interleukin-6 inhibition in ST-elevation myocardial infarction: Immune cell profile in the randomised ASSAIL-MI trial
por: Huse, Camilla, et al.
Publicado: (2022)

Serum Fatty Acids, Traditional Risk Factors, and Comorbidity as Related to Myocardial Injury in an Elderly Population with Acute Myocardial Infarction
por: Laake, Kristian, et al.
Publicado: (2016)

Serum Levels of Dihomo-Gamma (γ)-Linolenic Acid (DGLA) Are Inversely Associated with Linoleic Acid and Total Death in Elderly Patients with a Recent Myocardial Infarction
por: Nilsen, Dennis Winston T., et al.
Publicado: (2021)

Interleukin-18 Is a Strong Predictor of Cardiovascular Events in Elderly Men With the Metabolic Syndrome: Synergistic effect of inflammation and hyperglycemia
por: Trøseid, Marius, et al.
Publicado: (2009)

Rationale for the ASSAIL-MI-trial: a randomised controlled trial designed to assess the effect of tocilizumab on myocardial salvage in patients with acute ST-elevation myocardial infarction (STEMI)
por: Anstensrud, Anne Kristine, et al.
Publicado: (2019)

Circulating levels of IL-18 are significantly influenced by the IL-18 +183 A/G polymorphism in coronary artery disease patients with diabetes type 2 and the metabolic syndrome: an Observational Study
por: Opstad, Trine B, et al.
Publicado: (2011)

The MMP-9 -1562 C/T Polymorphism in the Presence of Metabolic Syndrome Increases the Risk of Clinical Events in Patients with Coronary Artery Disease
por: Opstad, Trine B., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_4nmg3mi1j531egc9ooje9knri9